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Galactofuranose (Galf) is a novel sugar absent in mammals but present in a variety of pathogenic microbes,
often within glycoconjugates that play critical roles in cell surface formation and the infectious cycle. In pro-
karyotes, Galf is synthesized as the nucleotide sugar UDP-Galf by UDP-galactopyranose mutase (UGM) (gene
GLF). Here we used a combinatorial bioinformatics screen to identify a family of candidate eukaryotic GLFs
that had previously escaped detection. GLFs from three pathogens, two protozoa (Leishmania major and
Trypanosoma cruzi) and one fungus (Cryptococcus neoformans), had UGM activity when expressed in Escherichia
coli and assayed in vivo and/or in vitro. Eukaryotic GLFs are closely related to each other but distantly related
to prokaryotic GLFs, showing limited conservation of core residues around the substrate-binding site and
flavin adenine dinucleotide binding domain. Several eukaryotes not previously investigated for Galf synthesis
also showed strong GLF homologs with conservation of key residues. These included other fungi, the alga
Chlamydomonas and the algal phleovirus Feldmannia irregularis, parasitic nematodes (Brugia, Onchocerca, and
Strongyloides) and Caenorhabditis elegans, and the urochordates Halocynthia and Cionia. The C. elegans open
reading frame was shown to encode UGM activity. The GLF phylogenetic distribution suggests that Galf
synthesis may occur more broadly in eukaryotes than previously supposed. Overall, GLF/Galf synthesis in
eukaryotes appears to occur with a disjunct distribution and often in pathogenic species, similar to what is seen
in prokaryotes. Thus, UGM inhibition may provide an attractive drug target in those eukaryotes where Galf
plays critical roles in cellular viability and virulence.
In many microbes, the sugar galactofuranose (Galf) is an
important constituent of glycoconjugates comprising major
portions of the cell surface (17). In prokaryotes, Galf consti-
tutes a key part of the mycobacterial cell wall and occurs in
lipopolysaccharide (LPS) O-antigen domains, extracellular
capsules, and polysaccharides (17, 19). In fungi such as Asper-
gillus, Galf is a major component within the cell wall and
structural glycoproteins (13, 17). In pathogenic protozoa, Galf
residues are key components of abundant surface glycosyl-
phosphoinositol-anchored glycoconjugates, such as lipophos-
phoglycan (LPG) and glycoinositolphospholipids in Leishma-
nia, and of mucins, glycosylphosphoinositol-anchored proteins,
and lipids in Trypanosoma cruzi (6, 18). In contrast, Galf resi-
dues have not been found in humans or other metazoans (17),
suggesting that inhibition of Galf synthesis could be an attrac-
tive target for chemotherapy in pathogens when its role(s) is
critical for survival or virulence (17, 32).
The Galf synthetic pathway has been best studied for pro-
karyotes. Genetic and biochemical studies have shown that
Galf arises through the action of UDP-galactopyranose mutase
(UGM) (EC 5.4.99.9), which catalyzes the rearrangement of
UDP-galactopyranose (Galp) to UDP-Galf, the substrate of
cellular UDP-Galf transferases which participate in path-
ways such as LPS or cell wall biosynthesis (15, 16). The gene
encoding UGM, GLF, was first located and hypothesized as
such by Reeves and colleagues as part of genetic and structural
studies of Escherichia coli K12 O antigen (27). It was then
definitively identified and studied in E. coli, Klebsiella, and
Mycobacteria (10, 15, 16). UGM is a flavin-dependent enzyme,
and the E. coli enzyme structure has been solved (21). A de-
tailed picture of the enzymatic mechanism involving a novel
form of flavin-dependent catalysis has been developed (24).
High-throughput assays for inhibitor screens have been de-
veloped, and a number of compounds showing activity against
UGM activity and/or bacteria have been identified (22, 25,
28).
Less is known about the Galf synthetic pathway in eukary-
otes. Previous efforts had not yielded the eukaryotic enzyme
responsible for synthesis of their UDP-Galf substrate, although
as in prokaryotes this was thought to arise by conversion of
UDP-Galp to UDP-Galf (29). In the parasitic protozoan Leish-
mania, several genes encoding putative UDP-Galf transferases
have been identified, including LPG1, which has been impli-
cated in the synthesis of the core of the abundant surface
glycoconjugate LPG (7, 20). Notably, the Leishmania genome
encodes at least 6 candidate UDP-Galf transferases (34), and
there are more than 20 related genes present in Trypanosoma
cruzi (34) (unpublished data). No candidate UDP-Galf trans-
ferases have been reported in fungi, although they must exist
given the number of Galf-containing glycoconjugates known in
these organisms. In this report we have used a bioinformatics
approach to identify the eukaryotic GLF gene family. We ex-
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pressed four diverse members of this family in E. coli and
demonstrated their activity in vivo and/or in vitro.
MATERIALS AND METHODS
PCR and construction of pET3 derivatives. For Leishmania major, PCR oli-
gonucleotides SMB2179 (5-GCATGCCATATGAGCGCTGACAAGGTGGT
CATAATC) and SMB2180 (5-GCATGCGGATCCTACGAGGCCGTCGAC
GACCATGTGCA) (underlined bases represent sites added for subsequent
cloning) were based upon the open reading frame (ORF) Lm18.0200 annotated
in release 4.0 of the Leishmania major genome (www.genedb.org/genedb/leish).
The PCR template was genomic DNA of L. major Friedlin (MHOM/IL/81/
Friedlin) clone V1, and amplification was performed with 35 cycles of 30 s at
93°, 45 s at 50°, and 150 s at 68°C. For Trypanosoma cruzi, PCR oligonucleo-
tides SMB2182 (5-GCATGGCCATATGGCAGAATTATTGACACCGAAA
ATTG) and SMB2230 (5-GCGATAGGATCCTCACATATCCTTCTGCAGT
AGT) were based upon the second of two ORFs (Tc00.1047053511277.600 and
Tc00.1047053507993.160) annotated in release 3.0 of the Trypanosoma cruzi
genome project (www.genedb.org/genedb/tcruzi). The PCR template was DNA
from the CL Brener strain of T. cruzi used for genome sequencing (kindly
provided by D. Barthomoleu, The Institute for Genomic Research), and ampli-
fication was performed with 35 cycles of 30 s at 93°C, 45 s at 49°C, and 150 s at
68°C. For Cryptococcus neoformans, PCR primers Galf-S (5-GGAATTCCATA
TGCCGTCCAGACTTGATTTT) and Galf-AS (5-CGGGATCCCTACTTCA
AGCGCCTCTCGA) were based upon ORF177.m02862 (The Institute for Ge-
nome Research; www.tigr.org/tdb/e2k1/cna1/index.shtml). Total RNA was iso-
lated from C. neoformans serotype D strain JEC43 and converted to cDNA
using the SuperScript First-Strand synthesis system as recommended by the
manufacturer (Invitrogen, Carlsbad, CA). PCR amplification using HIFI Taq
polymerase (Invitrogen, Carlsbad, CA) was performed with 30 cycles of 60 s at
94°C, 60 s at 55°C, and 120 s at 72°C. For C. elegans, gene predictions for the GLF
ORF H04M03.4 were obtained from WormBase (http://www.wormbase.org).
One internal region had not been determined experimentally, and we found by
sequence analysis of several cDNAs (expressed sequence tags [ESTs] yk1442e06,
yk1480e04, and yk1626a12 from Yuji Kohara, National Institute of Genetics,
Mishima, Japan; GenBank accession no. DN856302-6; and ORF clone
10013@E10, obtained from Open Biosystems, Inc., Huntsville, AL) that the
current gene model had missed a short intron, resulting in a predicted 9-amino-
acid insertion (SVYCFLREV) not encoded by any of the three cDNAs se-
quenced. The C. elegans H04M03.4 ORF contained an internal NdeI site, re-
quiring a series of PCR and cloning steps starting with the 10013@E10 cDNA
template prior to insertion into the pET3A NdeI-BamHI sites.
All PCRs yielded products with the expected sizes, which as necessary were
digested with NdeI and BamHI, ligated to pET-3A vector DNA previously
digested with the same enzymes, and transformed into E. coli DH10B or DH5,
yielding pET3a-LmGLF, pET3a-CnGLF, pET3a-TcGLF, or pET3a-CeGLF (lab
strains B5234, B5300, B5330, and B5425, respectively). The authenticity of
candidate recombinants was confirmed by DNA sequencing (GenBank ac-
cession numbers AY900624, AY900625, AY900626, and BK005688, respec-
tively). For T. cruzi GLF, our sequence corresponded well with the provi-
sional Tc00.1047053511277.600 ORF, with three differences (GTG3 GCA/
Val3Ala in the second codon and a silent A3G transition at nucleotide 1413).
The first two differences may represent “cross priming” of the 5 oligonucleotide
used in PCR.
For rescue of Galf-dependent LPS biosynthesis, the pET-GLF constructs
above were introduced into E. coli strain CWG288pWQ70 (10), yielding strains
B5364, B5363, B5365, and B5431, respectively. As described in more detail
below, CWG288 contains a deletion of the E. coli rfb locus, while plasmid
pWQ70 contains the rfb locus of Klebsiella pneumoniae bearing a deletion of the
GLF gene (see reference 10 for the complete genotype and characterization of
these). For enzymatic assays, two of the pET-GLF constructs were introduced
into the E. coli host strain BL21(DE3) (B5304), yielding pET-LmGLF/BL21
(DE3) and pET-CnGLF/BL21(DE3) (B5235 and B5303, respectively). Compar-
ative phylogenetic analyses were conducted using MEGA version 3.0 (11).
LPSWestern blotting. For immunoblotting, cells were pelleted from 1 ml of an
overnight E. coli culture, suspended in 50 l of sample buffer (62.5 mM Tris, 2%
sodium dodecyl sulfate, 10% glycerol, 2.5% -mercaptoethanol, and 0.05%
bromphenol blue), and boiled for 10 min. Samples were diluted fivefold further
with sample buffer, and 5 l was loaded on a discontinuous gel consisting of a 4%
stacking gel above a 12.5% Tris-glycine separating gel (12). Fresh preparations
gave the best results. Gels were run at 200 V for 40 min and electroblotted to
nitrocellulose (Hybond-ECL; Amersham Biosciences) overnight at 54 mA.
Western blotting was performed with rabbit anti-Klebsiella galactan I (generously
provided by Whitfield and Clarke, U. Guelph) at a titer of 1:10,000 for 2 h at
room temperature in 5% milk in TBST (10 mM Tris, 150 mM NaCl, 0.05%
Tween 20 [vol/vol]). Binding was visualized with peroxidase-conjugated goat
anti-rabbit immunoglobulin G (Jackson ImmunoResearch, catalog no. 111-
035-003) at a titer of 1:20,000 in TBST for 1 h at room temperature followed by
detection by chemiluminescence (Western Lightning, Perkin-Elmer Life Sci-
ences, catalog no. NEL100).
UGM enzyme assays. One-liter cultures of E. coli BL21(DE3)/pET3a-CnGLF
expressing Cryptococcus GLF (B5303), E. coli BL21(DE3)/pET3a-LmjGLF ex-
pressing Leishmania GLF (B5235), or E. coli BL21(DE3) without plasmid were
grown overnight at 37°C in LB broth. Strains bearing pET3a-GLF constructs
were grown in the presence of 100 g/ml ampicillin. All cultures were induced by
addition of 0.5 mM isopropyl--D-thiogalactopyranoside, followed by incubation
at 22°C with shaking at 90 rpm for 3 h. Cultures were harvested by centrifugation,
and cell pellets were resuspended in 20 ml 100 mM potassium phosphate buffer
(pH 7.0) containing 0.15 M NaCl, 15% glycerol, 10 mM flavin adenine dinucle-
otide (FAD), 0.1 mM phenylmethylsulfonyl fluoride, 1 M pepstatin A, and
1 M leupeptin. The cells were broken by three passages through a French press
and centrifuged at 20,000  g for 40 min at 4°C. The supernatant fractions were
frozen at 80°C until use.
UDP-Galf was synthesized enzymatically from UDP-Galp and purified as de-
scribed previously (14). Activity assays were performed in 96-well PCR plates.
Each well contained 50 M UDP-Galf, 100 mM phosphate buffer at pH 7, 1 mM
MgCl2, 15% glycerol, protein (80 to 10,000 ng E. coli extract expressing Crypto-
coccus GLF, 35 to 4,400 ng E. coli extract expressing Leishmania GLF, or 27,400
ng control E. coli BL21(DE3), and 20 mM sodium dithionite (to reduce the FAD
to FADH2) in a 20-l volume. FAD was added in various amounts depending on
how much protein was added (final concentrations of 1.6 to 1,000 M). Reac-
tions were incubated at 30°C for 6 min and stopped by the addition of 40 l 95%
ethanol. Samples were analyzed by high-performance liquid chromatography
(HPLC) as described previously (14), except that the solvent system was modified
by elution of the sugar nucleotides for 10 min with 200 mM KH2PO4 followed by
a 600 mM KH2PO4 wash. Yields of UDP-Galp were calculated from the relative
fraction of UDP-Galf and UDP-Galp in the samples and the knowledge that 1
nmol of UDP-Galf was originally added to each well.
RESULTS
Identification of candidate GLFs. Although the first pro-
karyotic GLF was identified in 1996, previous efforts to detect
eukaryotic GLFs had not been successful. Recently the ge-
nomes of several eukaryotic pathogens known to synthesize
Galf progressed towards completion, and we applied a combi-
natorial bioinformatics screen to these genomes in an effort to
identify candidate GLFs. Briefly, these involved a combination
of (i) BLAST searches with prokaryotic GLFs, (ii) searches for
flavin binding domains, and (iii) appropriate phylogenetic dis-
tribution, specifically occurrence in fungi and protozoa known
to synthesize Galf but absence from taxa lacking Galf. Since the
presence of Galf has not been systematically addressed for
many microbial and metazoan species, we applied the latter
criterion conservatively. We focused these studies initially on
the Leishmania major genome, using ORF predictions devel-
oped by the Leishmania genome project (release 4.0, August
2004; see www.genedb.org/genedb/leish).
While many ORFs satisfied each of these criteria individu-
ally (albeit often quite weakly), a single candidate L. major
ORF was identified in the combined screen. The Lm18.0200
GLF sequence predicted a 491-amino-acid protein, which
showed a weak relationship to the Pfam family of flavin-con-
taining amine oxidoreductases (PB010804; e  6  104),
including a potential FAD binding motif at amino acids 6 to 19
(Fig. 1, underlined by parallel lines). The three-dimensional
structure of E. coli UGM has shown that the FAD binding
domain actually encompasses a much larger portion of the
protein (21), and limited sequence conservation homology was
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also evident throughout this region (Fig. 1, underlined by dark
lines). BLAST searches of a variety of databases, including
unfinished microbial genomes, revealed a number of strong
BLAST hits (P 	 1040), most of which were annotated as
hypothetical proteins although several were annotated as
amine oxidases (Table 1; Fig. 2). Notably, in every case where
sequence from organisms capable of Galf synthesis was ana-
lyzed, strong BLAST hits to Lm18.0200 were present. These
included the protozoans Leishmania infantum and T. cruzi and
the fungi Aspergillus, Cryptococcus, and Neurospora (Fig. 2; Ta-
ble 1). Correspondingly, homologs of the candidate L. major
GLF were not detected in vertebrates, nor in Trypanosoma bru-
cei, Saccharomyces cerevisiae or Schizosaccharomyces pombe,
species where Galf may be absent. Prokaryotic GLF/UGMs
yielded weak BLAST scores (
0.2) across only the N-terminal
portion of the Leishmania UGM, which undoubtedly contrib-
uted to the eukaryotic genes being overlooked previously.
Comparison of the predicted proteins encoded by the L.
major, T. cruzi, and Cryptococcus neoformans GLFs to that of
E. coli UGM/GLF (Fig. 1; Table 1) shows that the overall
similarity to prokaryote GLFs is relatively low. Most regions of
sequence conservation fall within the FAD binding domains
determined previously from the structure of E. coli UGM (Fig.
1, underlined regions) (21). Significantly, genetic and structural
analyses have identified a number of residues possibly involved
in UDP-Galp binding, and with few exceptions these residues
were identical in prokaryotic and eukaryotic GLF proteins
(Fig. 1, residues shaded in orange). These residues were also
conserved within the strong database hits noted elsewhere in
this section (data not shown). The candidate eukaryotic GLF
proteins showed a high degree of identity to each other (Fig. 1
and 2; Table 1).
While the correlation of GLF candidates with species known
to carry out Galf synthesis was encouraging, strong BLAST hits
were also obtained to sequences from a number of organisms
not known to synthesize Galf, including the nematodes C. ele-
gans and Caenorhabditis briggsae, the urochordate Halocynthia,
and the algal Feldmannia irregularis virus (Table 1). A number
of ESTs encoding partial GLFs were found in parasitic nem-
atodes, including Brugia malayi, Onchocerca volvolus, Strongy-
loides stercoralis and Strongyloides ratti, Heterodura glycine, and
Meloidogyne hapla and Meloidogyne arenaria (see Table S1 in
FIG. 1. Alignment of key eukaryotic and prokaryotic GLF proteins. The predicted proteins encoded by the L. major, T. cruzi, C. neoformans,
and C. elegans GLF ORFs were aligned with that of E. coli using methods implemented in the Clustal program (4); the unedited alignment is
shown. The amino acid positions are shown on the right, and asterisks mark 10-amino-acid intervals in the alignment. Residues identical in 5/5
sequences are shaded in blue, and residues identical in 4/5 sequences are shaded gray. Residues proposed as part of UDP-Galp binding site are
shaded orange (all but one of these are 5/5 identities). The dark underlined regions correspond to the flavin-binding region of E. coli UGM (21);
a smaller region showing homology to the Pfam family flavin-containing amine oxidoreductases (PB010804; residues 6 to 19 of the L. major UGM)
is underlined by two parallel lines.
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the supplemental material), and we were able to assemble com-
plete ORFs for the urochordate Ciona intestinalis and the alga
Chlamydomonas reinhardtii (Table 1; see Tables S1 and S2 in
the supplemental material). Several strong hits (P	 1085) were
obtained to eubacterial sequences annotated as “amine oxi-
dases,” although enzymatic data supporting these assignments
were lacking. Strong hits (P 	 1028 to 1015) were also ob-
tained with sequences from three archea (Pyrococcus horiko-
shii, Pyrobaculum aerophilum, and Methanococcus maripaludis)
(Table 1). A phylogenetic tree depicting relationships among
the eukaryotic candidates is shown in Fig. 2, and an alignment
of the C. elegans ORF H04M03.4 is included in Fig. 1. As
observed for the fungal and protozoal homologs, candidate
flavin-binding regions and UDP-Galp binding residues were
conserved in these predicted proteins (Fig. 2; also data not
shown). Genes or proteins showing significant relationship
were not observed in BLAST searches of the genomes of
Giardia lamblia, Trichomonas vaginalis, Entamoeba, apicompl-
exans including Toxoplasma and Plasmodium, Tetrahymena, or
several plant genomes including Arabidopsis.
The imperfect concordance between the occurrence of eu-
karyotic GLF sequences and Galf synthesis could arise from
incomplete knowledge of Galf synthesis and/or an incorrect
assignment of this gene family (or individual members therein)
as encoding active UGMs. Thus, we sought confirmation that
representative candidate GLF ORFs encoded UGM activity.
Rescue of Galf-dependent LPS synthesis in E. coli. We de-
veloped an in vivo complementation assay for UDP-Galf syn-
thesis in E. coli, adapted from work by Whitfield and col-
leagues (10). These authors showed that expression of the
Klebsiella rfbKPO1 locus in an E. coli strain deleted for the
endogenous LPS rfb locus led to the synthesis of LPS O1
antigen bearing the repeating unit [33)--D-Galf-(133)--D-
Galp-(13]. Notably, inactivation of the Klebsiella GLF gene
rfbDKPO1 abrogated LPS biosynthesis, which could be restored
by episomal expression of KpGLF. We surmised that this
would provide a rapid and convenient test for the activity of
FIG. 2. Phylogenetic tree of the eukaryotic GLF family ORFs. A
minimum evolution tree for the predicted protein sequences of can-
didate eukaryotic GLFs was constructed using algorithms implicated in
the MEGA3 software package (11). A “” marks species where Galf
has been detected; Galf has not been examined in the other taxa shown.
Species where the GLF-encoded UGM activity was confirmed in this
work are boxed. For information on the specific sequences analyzed, see
Table 1 and Table S2 in the supplemental material. The scale at the
bottom corresponds to the fraction of amino acid sequence difference.
TABLE 1. Genes showing strong similarity to eukaryotic GLFsa
Species Group Speciescontains Gal?b Gene Annotation
c Blastp P value % Identity
Leishmania major Protists YES Lmj18.200 UGM (query) 100
Trypanosoma cruzi Protists YES Tc00.1047053511277.600 UGM 10160 58
Tc00.1047053507993.160
Aspergillus nidulans Fungi YES EAA63683 Hyp. 10117 45
Neurospora crassa Fungi YES EAA27372 Hyp. 10117 44
Magneporthe grisea Fungi UNK EAA55038 Hyp. 10115 44
Gibberella zeae Fungi UNK EAA75642 Hyp. 10113
Cryptococcus neoformans Fungi YES EAL19520 UGM 10111 42
Chlamydomonas rheinhardtii Green algae UNK Table S2d 10110 42
Ustilago maydis Fungi UNK UM03094 Hyp. 10104 40
Geobacter sulfurreducens Eubacteria UNK AAR34886 Flavin amine oxidase 10103 44
Desulfovibrio vulgaris Eubacteria UNK AAS94778 Flavin amine oxidase 1091 40
Desulfovibrio desulfuricans Eubacteria UNK ZP00346806 Protoporphyrinogen oxidase 1085 37
Feldmannia irregularis virus Algal virus UNK AAR26880 Hyp. 1084 38
Caenorhabditis briggsae Nematodes UNK CAE72630 Hyp. 1068 34
Caenorhabditis elegans Nematodes UNK AAD12787 UGM 1068 34
Ciona intestinalis Nematodes UNK Table S2 1062 31
Halocynthia roretzi Urochordates UNK BAB20903 HrTLCl 1046 26
Pyrococcus horikoshii Archea UNK B71153 Hyp. 1027 27
Pyrobaculum aerophilum Archea UNK AAL62855 Hyp. 1026 27
Yersinia pseudotuberculosis Eubacteria PROB CAB63294 O-antigen WbyH 1018 22
Methanococcus maripaludis Archea UNK CAF30324 Hyp. 1014 21
Klebsiella pneumonia
(prokaryotic GLF)
Eubacteria YES Q48485 UGM 0.2 	10%
(only N-term)e
a The genes are ordered based on their BlastP P value, based on searches with the L. major GLF query sequence.
b YES, evidence showing occurrence of Galf in one or more glycoconjugates; PROB, Galf suspected to be present; UNK, not investigated or established.
c Hyp., hypothetical protein. Annotations of L. major, T. cruzi, C. neoformans, and C. elegans GLFs reflect GenBank depositions arising from this work.
d See the supplemental material.
e N-term, N-terminal.
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potential heterologous GLFs. Accordingly, we obtained the
L. major, T. cruzi, C. neoformans, and C. elegans GLF ORFs
by PCR and introduced them into the bacterial expression
vector pET3a. These were then introduced into E. coli strain
CWG288 (deleted for the endogenous rfb locus) containing
plasmid pWQ70, which bears the Klebsiella rfbKPO1 locus with
an inactivated GLF (rfbD) gene (10). LPS expression was mon-
itored by Western blotting with rabbit anti-galactan I antibody,
which recognizes a [Galf-Galp] repeating unit (5).
We confirmed that the intact Klebsiella rfb locus restored
Galf-containing O1 LPS biosynthesis in E. coli strain CWG288
transformed with pWQ71, which bears an intact rfb locus,
while plasmid pWQ70 bearing the inactivated GLF failed to
do so (Fig. 3, lane 1 versus lane 2). Transformation of strain
CWG288/pWQ70 with any of the four eukaryotic species’
pET3a-GLF constructs (L. major, T. cruzi, C. neoformans, or
C. elegans) resulted in synthesis of LPS reactive with anti-
Klebsiella galactan I antisera, at levels comparable to those
of the controls (Fig. 3, lanes 4 to 7). As expected, neither
pET3a nor a frameshift mutant C. elegans GLF rescued LPS
expression (Fig. 3, lanes 3 and 8, respectively). These data
suggested that the eukaryotic candidate GLFs mediated Galf
synthesis when expressed heterologously in E. coli.
While our data suggest that similar levels of LPS restoration
were seen in the experimental versus control samples, some
restraint is required in interpreting these data. As shown be-
low, the eukaryotic UGMs are largely insoluble when ex-
pressed in E. coli. Thus, differences in the degree of eukaryotic
GLF rescue of LPS expression may reflect either intrinsic dif-
ferences in catalytic activity of the enzymes or “noise” arising
from differences in expression and/or folding. Nonetheless,
these data suggest that the eukaryotic UGMs are able to pro-
vide sufficient UDP-Galf under these conditions for LPS syn-
thesis comparable to that of authentic bacterial UGMs.
UGM activity of L. major and C. neoformans GLFs. To con-
firm directly that candidate GLFs encoded UGM activity, we
first expressed high levels of protein in E. coli using the pET3a
system. While abundant expression was evident in sodium do-
decyl sulfate-PAGE analysis, the majority of protein appeared
in insoluble inclusion bodies (data not shown). Nonetheless,
soluble protein extracts were prepared, and UGM activity was
assayed in the reverse direction, following the conversion of
UDP-Galf to UDP-Galp by HPLC (14). Since the E. coli strain
BL21(DE3) lacks GLF, there was no endogenous background
UGM activity in crude preparations (15) (Fig. 4E and F). In
contrast, with extracts from cells expressing L. major or
C. neoformans GLFs, the UDP-Galf substrate was converted to
UDP-Galp (Fig. 4C and D) in a protein-dependent manner
(Fig. 4A and B). These data establish that these eukaryotic
GLFs encode proteins with UGM activity. In the future, stud-
ies of purified soluble and active eukaryotic UGMs will address
the catalytic properties of these enzymes relative to those of
prokaryotes in more detail.
DISCUSSION
By using a combinatorial bioinformatics approach incorpo-
rating criteria including sequence homology, protein motifs,
and phylogenetic associations with Galf synthesis, we identified
a candidate Leishmania GLF gene and from this a large family
of potential eukaryotic GLFs. We used a rapid in vivo assay of
GLFs expressed in E. coli as a first screen for UGM activity of
several candidate eukaryotic proteins (Fig. 3), which were con-
firmed subsequently in enzymatic assays (Fig. 4). While the eu-
karyotic UGM/GLF proteins show some relationship to the
previously described prokaryotic enzymes, the amino acid se-
quence divergence was extensive, and the correlation of po-
tential GLF homologs with organisms known to synthesize
Galf was imperfect. Perhaps for these reasons, eukaryotic
GLFs had remained elusive despite efforts undertaken by
many researchers.
Despite the extensive divergence, eukaryotic UGMs share
key properties with those of prokaryotes. The eukaryotic pro-
teins contain clear flavin binding motifs, and most importantly,
a number of residues implicated by functional or structural
criterion in substrate binding were conserved (Fig. 1). Prelim-
inary analysis suggests that the eukaryotic UGMs can be read-
ily modeled to the E. coli UGM structure determined previ-
ously, with a number of sequence insertions potentially mapping
to external loops (data not shown). As in prokaryotes, eukary-
otic UGMs lack obvious secretory signals and are likely to be
FIG. 3. In vivo rescue of Galf-dependent LPS synthesis in E. coli.
Bacterial lysates were prepared and subjected to Western blot analysis
with rabbit anti-Klebsiella galactan I antisera as described in Materials
and Methods. The migration of molecular mass markers (in kDa) is
shown on the left, and the region corresponding to migration of LPS is
shown by the bracket on the right; the antiserum also reacts with
low-molecular-weight material (perhaps lipid A and LPS core), but the
identification of O antigen is unequivocal. All strains derive from the
E. coli rfb deletion strain CWG288. Plasmids introduced were as fol-
lows: lane 1, pWQ71 (intact Klebsiella rfb locus; positive control);
lane 2, pWQ70 (pWQ71 with deletion inactivating GLF); lane 3,
pWQ70pET3a (vector control); lane 4, pWQ70pET3a-LmjGLF;
lane 5, pWQ70pET3a-TcGLF; lane 6, pWQ70pET3a-CnGLF;
lane 7, pWQ70pET3a-CeGLF; and lane 8, pWQ70  inactive mu-
tant pET3a-CeGLF (clone 1.1, strain B3597, which contains a 1-nt
deletion at position 129 introducing a premature stop amongst other
PCR-generated mutations). The experiment shown in lanes 7 to 8 was
performed separately from those shown in lanes 1 to 6.
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cytoplasmic. Since the bulk of eukaryotic glycoconjugate syn-
thesis typically occurs within the secretory pathway, this sug-
gests that one or more nucleotide sugar transporters must
recognize and transport UDP-Galf to lumenal compartments.
We found a number of genes with strong homology to GLFs
encoding eukaryotic UGMs in species not known to synthesize
Galf (Fig. 1 and 2; Table 1; see Tables S1 and S2 in the sup-
plemental material). These predicted proteins also showed
conservation of key UGM substrate-binding residues (Fig. 1,
data not shown). Since the phylogenetic tree presented in Fig.
2 showed that members of both major branches of the eukary-
otic GLF family had UGM activity, by parsimony we believe
that most or all of these candidate GLFs encode proteins with
UGM activity as well. Given the paucity of information on Galf
in eukaryotes outside of fungi and protozoa, these new eukary-
otic GLFs raise the possibility that Galf synthesis may occur
more widely in species than previously supposed. For fungi
such as Ustilago, Magneporthe, and Giberella, this was unsur-
prising, but the occurrence of eukaryotic GLFs in the nema-
todes C. elegans, the urochordates Ciona and Halocynthia, and
the algae Chlamydomonas and algal virus Feldmannia (Fig. 1;
Table 1; see Tables S1 and S2 in the supplemental material)
was unanticipated. Notably, our data show that C. elegans GLF
encodes a protein with UGM activity. Additionally, we found
strong GLF homologs in a variety of unfinished genome and
EST surveys, including Histoplasma capsulatum, which con-
tains Galf within sphingolipids (2), and nematode parasites
of humans (Brugia malayi and Onchocerca volvulus), animals
(Strongyloides), and plants (Heterodura and Meloidogyne) (see
Table S1 in the supplemental material) (3, 33).
Assuming that the presence of eukaryotic GLF within a
species is predictive of Galf synthesis, our analyses suggest that
the phylogenetic distribution of the GLF/Galf synthetic path-
way shows some features reminiscent of those seen in pro-
karyotes. First, the GLF/Galf pathway occurs only sporadically,
in widely divergent species, and second, it is often found in
pathogenic/parasitic species from both the microbial and meta-
zoan worlds. Why pathogens show an affinity for inclusion of
Galf in their metabolomic repertoire is unknown; potential
explanations might include the strong immunogenicity of Galf
and/or its ability to adopt novel structural conformations (17,
31), both of which could contribute to microbial virulence and
survival. Notably, the GLF relationships depicted in Fig. 2 or
evident in Table 1 often do not closely follow those of the
species involved. Potentially, the predilection of pathogens for
Galf could be a contributing factor to the sporadic distribution
of Galf synthesis among species, perhaps by lateral gene trans-
fer mechanisms as seen in bacterial LPS O antigens (19). The
presence of a GLF within the algal virus Feldmannia (Fig. 2) is
FIG. 4. UGM assays of eukaryotic GLFs expressed in E. coli. Protein-containing supernatants were prepared, and UGM activity was assayed
by monitoring conversion of UDP-Galf to UDP-Galp by HPLC (15) as described in Methods. Panels A and B show the production of UDP-Galp
as a function of added protein extract. (A) Extract from E. coli expressing C. neoformans GLF [BL21(DE3)/pET3a-CnGLF]; (B) Extract from
E. coli expressing Leishmania GLF [BL2(DE3)/pET3a-LmjGLF]. Panels C-F show representative HPLC traces and controls used to generate the
data in panels A and B. (C) The 10-g protein point from (A); (D) the 4.4-g protein point from (B); (E) 28 g of protein incubated from E. coli
BL21(DE3) incubated under standard assay conditions. In the standard assay, the total amount of UDP-Galf added was 1 nmol. Panel F shows
28 g of protein incubated from E. coli BL21(DE3) incubated without UDP-Galf, showing that the small peak in (E) comes from endogenous
UDP-Galp or UDP-Glc from E. coli.
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interesting in this light, since viruses often can be transmitted
laterally among species.
Galf-containing glycoconjugates are often dominant features
of the surface of many protozoans and fungi, making Galf syn-
thesis a potential target for chemotherapy. However, the role
of Galf conjugates in the survival and virulence of eukaryotic
microbes appear to vary greatly among species. For example,
in fungi, Galf comprises only a small portion of the Cryptococ-
cus capsule (30) but a major fraction of the abundant galacto-
mannans in Aspergillus (13). Interestingly, in several global
surveys of gene function using RNA interference approaches,
inhibition of the C. elegans GLF encoded by gene H04M03.4
showed a variety of deleterious effects (1, 8, 23); future studies
will be required to establish whether this involves Galf-contain-
ing glycoconjugates. Preliminary tests of a panel of prospective
prokaryotic UGM inhibitors (22) suggest that they fail to in-
hibit the eukaryotic UGMs studied here (unpublished work),
in keeping with the extensive amino acid sequence divergence
(Fig. 1). Thus, it will be necessary to identify eukaryote-specific
UGM inhibitors in the future. Interestingly, it has recently
been suggested that several of the inhibitors of the Mycobac-
terium tuberculosis UGM may also act against bacteria inde-
pendently of UGM (28).
For Leishmania, genetic studies suggest that parasites lack-
ing Galf glycoconjugates, such as LPG and glycoinositolphos-
pholipids, retain virulence in mammalian infections, although
their ability to be transmitted by the insect vector sand fly is
greatly reduced (26, 34, 35). Whether a similar conclusion
pertains to Trypanosoma cruzi, where Galf-containing mol-
ecules are also highly abundant in infective stages, awaits
confirmation (18). Given that the Leishmania and T. cruzi
genomes encode numerous potential UDP-Galf transferases
(34), genetic inactivation of their GLFs (which occur in one
or two copies, respectively; Table 1) may offer an easier defin-
itive test (9). Interestingly, T. brucei, which is thought to be
evolutionarily more closely related to T. cruzi than Leishmania,
lacks GLF and Galf-containing conjugates. While this could
arise from evolutionary loss of GLF in this lineage, the com-
plex disjunct distribution and relationships of GLF genes in
other eukaryotic taxa suggest that other explanations cannot
yet be ruled out.
In summary, we have identified a large eukaryotic GLF
family and provided evidence that members of the two major
groups within this family possess UGM activity. This in turn
has permitted predictions about the occurrence of Galf syn-
thesis among species and its frequent appearance within both
microbial and metazoan pathogens. Future work will focus on
exploitation of UGM-targeted inhibitors in chemotherapy and
determination of the structure and role of Galf in those lin-
eages for which information is currently lacking.
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